Literature DB >> 9200364

Mortality within the first 2 years in infants exposed to cocaine, opiate, or cannabinoid during gestation.

E M Ostrea1, A R Ostrea, P M Simpson.   

Abstract

OBJECTIVE: To determine the mortality rate, during the first 2 years of life, in infants who were exposed to cocaine, opiate, or cannabinoid during gestation.
METHODS: For a period of 11 months, a large group of infants were enrolled and screened at birth for exposure to cocaine, opiate, or cannabinoid by meconium analysis. Death outcome, within the first 2 years after birth, was determined in this group of infants using the death registry of the Michigan Department of Public Health.
RESULTS: A total of 2964 infants was studied. At birth, 44% of the infants tested positive for drugs: 30. 5% positive for cocaine, 20.2% for opiate, and 11.4% for cannabinoids. Compared to the drug negative group, a significantly higher percentage (P < .05) of the drug positive infants had lower weight and smaller head circumference and length at birth and a higher percent of their mothers were single, multigravid, multiparous, and had little to no prenatal care. Within the first 2 years of life, 44 infants died: 26 were drug negative (15.7 deaths per 1000 live births) and 18 were drug positive (13.7 deaths per 1000 live births). The mortality rate among cocaine, opiate, or cannabinoid positive infants were 17.7, 18.4, and 8.9 per 1000 live births, respectively. Among infants with birth weight </=2500 g, infants who were positive for both cocaine and morphine had a higher mortality rate (odds ratio = 5.9, confidence interval [CI] = 1.4 to 24) than drug negative infants. Eleven infants died from the sudden infant death syndrome (SIDS); 58% were positive for drugs, predominantly cocaine. The odds ratio for SIDS among drug positive infants was 1.5 (CI = 0.46 to 5.01) and 1.9 (CI = 0.58 to 6.2) among cocaine positive infants.
CONCLUSION: We conclude that prenatal drug exposure in infants, although associated with a high perinatal morbidity, is not associated with an overall increase in their mortality rate or incidence of SIDS during the first 2 years of life. However, a significantly higher mortality rate was observed among low birth weight infants (</=2500 g) who were positive for both cocaine and opiate.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9200364     DOI: 10.1542/peds.100.1.79

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  17 in total

1.  Prenatally buprenorphine-exposed children: health to 3 years of age.

Authors:  Kaisa Kivistö; Sarimari Tupola; Satu Kivitie-Kallio
Journal:  Eur J Pediatr       Date:  2015-05-24       Impact factor: 3.183

2.  Altered motor development following late gestational alcohol and cannabinoid exposure in rats.

Authors:  Kristen R Breit; Brandonn Zamudio; Jennifer D Thomas
Journal:  Neurotoxicol Teratol       Date:  2019-03-31       Impact factor: 3.763

3.  Beliefs and Behaviors of Pregnant Women with Addictions Awaiting Treatment Initiation.

Authors:  Amanda Van Scoyoc; Jill Ann Harrison; Philip A Fisher
Journal:  Child Adolesc Social Work J       Date:  2016-11-17

4.  Self-report of illicit substance use versus urine toxicology results from at-risk pregnant women.

Authors:  Kimberly A Yonkers; Heather B Howell; Nathan Gotman; Bruce J Rounsaville
Journal:  J Subst Use       Date:  2011-10-01

Review 5.  Economic evaluation of drug abuse treatment and HIV prevention programs in pregnant women: a systematic review.

Authors:  Jennifer Prah Ruger; Christina M Lazar
Journal:  Addict Behav       Date:  2011-08-05       Impact factor: 3.913

6.  Effects of prenatal exposure to marijuana.

Authors:  E Kozer; G Koren
Journal:  Can Fam Physician       Date:  2001-02       Impact factor: 3.275

Review 7.  Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review.

Authors:  D A Frank; M Augustyn; W G Knight; T Pell; B Zuckerman
Journal:  JAMA       Date:  2001-03-28       Impact factor: 56.272

8.  Enhancement of tolerance development to morphine in rats prenatally exposed to morphine, methadone, and buprenorphine.

Authors:  Yao-Chang Chiang; Tsai-Wei Hung; Cynthia Wei-Sheng Lee; Jia-Ying Yan; Ing-Kang Ho
Journal:  J Biomed Sci       Date:  2010-06-07       Impact factor: 8.410

9.  Pregnancy and sexual health among homeless young injection drug users.

Authors:  Dodi Hathazi; Stephen E Lankenau; Bill Sanders; Jennifer Jackson Bloom
Journal:  J Adolesc       Date:  2008-08-09

10.  Development and validation of a liquid chromatography mass spectrometry assay for the simultaneous quantification of methadone, cocaine, opiates and metabolites in human umbilical cord.

Authors:  Ana de Castro; Marta Concheiro; Diaa M Shakleya; Marilyn A Huestis
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-07-24       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.